HT Simonsen Holding ApS: Financial statements 2022
CVR: 37334308
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
HT Simonsen Holding ApS (CVR 37334308) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK -10,000 and a net result of DKK -10,040 compared with DKK 13,283 the year before. Equity in the 2022 report amounted to DKK 30,812. The solvency ratio was 100%.
- Revenue
- DKK 0
- Gross Profit
- DKK -10,000
- Profit/Loss
- DKK -10,040
- Equity
- DKK 30,812
- Total Assets
- DKK 30,812
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | 0 | -10 t. | -10 t. | 31 t. | - |
| 2021 | - | -2 t. | 13 t. | 48 t. | - |
| 2020 | - | -30 t. | -30 t. | 2 t. | - |
| 2019 | 0 | 0 | 0 | 32 t. | - |
| 2018 | 0 | -10 t. | -10 t. | 58 t. | - |
Official annual report
Keep an eye on HT Simonsen Holding ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
HT Simonsen Holding ApS has published its annual report for 2021. Gross profit came to DKK -1,800, and the net result was DKK 13,283.
About HT Simonsen Holding ApS
HT Simonsen Holding ApS is a Danish company of the type Anpartsselskab based in Glostrup, founded in 2016. The company is registered under the industry Ikke-finansielle holdingselskaber. The company was previously named HT Simonsen Holding IVS and Mosspiration Biotech IVS. The management consists of Henrik Toft Simonsen. The company is owned by Henrik Toft Simonsen. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -990 and a net result of DKK -990 compared with DKK -477 the year before. Equity in the 2025 report amounted to DKK 12,465.